We are live on ! Find out more
BIM

Baldwin Investment Management Portfolio holdings

AUM $1.03B
1-Year Est. Return 22.29%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+22.29%
3 Year Est. Return
+74.82%
5 Year Est. Return
+112.14%
10 Year Est. Return
+391.06%
AUM
$730M
AUM Growth
-$7.14M
Cap. Flow
-$4.93M
Cap. Flow %
-0.68%
Top 10 Hldgs %
61.38%
Holding
214
New
5
Increased
61
Reduced
104
Closed
9

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.58M
2
SNPS icon
Synopsys
SNPS
+$1.3M
3
BWA icon
BorgWarner
BWA
+$790K
4
ZTS icon
Zoetis
ZTS
+$645K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$611K

Sector Composition

Rank Sector Weight
1 Financials 54.28%
2 Technology 14.92%
3 Healthcare 7.57%
4 Industrials 4.7%
5 Consumer Discretionary 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KKR icon
151
KKR & Co
KKR
$92.3B
$474K 0.06%
4,500
NSP icon
152
Insperity
NSP
$2.01B
$468K 0.06%
5,135
-5
-0.1% -$506
GEHC icon
153
GE HealthCare
GEHC
$32.4B
$461K 0.06%
5,913
-290
-5% -$23.7K
SHW icon
154
Sherwin-Williams
SHW
$89.8B
$459K 0.06%
1,537
+448
+41% +$139K
CHKP icon
155
Check Point Software Technologies
CHKP
$13.1B
$458K 0.06%
2,773
-370
-12% -$57.7K
ITUB icon
156
Itaú Unibanco
ITUB
$87.5B
$432K 0.06%
83,792
+4,808
+6% +$26.3K
CL icon
157
Colgate-Palmolive
CL
$74.4B
$432K 0.06%
4,449
+250
+6% +$23.1K
SYY icon
158
Sysco
SYY
$40.3B
$429K 0.06%
6,015
-75
-1% -$5.6K
AVUV icon
159
Avantis US Small Cap Value ETF
AVUV
$30.9B
$422K 0.06%
4,708
-62
-1% -$5.62K
AON icon
160
Aon
AON
$76B
$411K 0.06%
1,400
PFE icon
161
Pfizer
PFE
$153B
$404K 0.06%
14,423
+100
+0.7% +$2.75K
WELL icon
162
Welltower
WELL
$171B
$392K 0.05%
3,760
+450
+14% +$44.1K
VWO icon
163
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$392K 0.05%
8,948
+3
+0% +$129
VEA icon
164
Vanguard FTSE Developed Markets ETF
VEA
$236B
$387K 0.05%
7,830
+128
+2% +$6.37K
GXO icon
165
GXO Logistics
GXO
$5.55B
$382K 0.05%
7,562
-2,800
-27% -$141K
AZN icon
166
AstraZeneca
AZN
$250B
$363K 0.05%
2,328
-50
-2% -$7.52K
SRPT icon
167
Sarepta Therapeutics
SRPT
$1.77B
$356K 0.05%
2,250
IBB icon
168
iShares Biotechnology ETF
IBB
$9.77B
$352K 0.05%
2,565
SRAD icon
169
Sportradar
SRAD
$3.85B
$351K 0.05%
31,351
-574
-2% -$5.97K
GLD icon
170
SPDR Gold Trust
GLD
$141B
$333K 0.05%
1,550
RL icon
171
Ralph Lauren
RL
$23.6B
$333K 0.05%
1,900
+100
+6% +$17.3K
CP icon
172
Canadian Pacific Kansas City
CP
$80.5B
$329K 0.05%
4,185
-14
-0.3% -$1.14K
ITW icon
173
Illinois Tool Works
ITW
$84.5B
$320K 0.04%
1,349
-100
-7% -$24.7K
VLTO icon
174
Veralto
VLTO
$24B
$319K 0.04%
3,346
-134
-4% -$12.8K
XLF icon
175
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$313K 0.04%
7,610
-280
-4% -$11.5K

Similar funds

Baldwin Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Baldwin Investment Management held 214 positions worth $730M, down 0.97% from $737M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Baldwin Investment Management's Q2 2024 filing shows 5 new, 61 increased, 104 reduced and 9 closed positions. Its largest new stake was Synopsys: 2,291 shares worth $1.36M. The largest sale was Pioneer Natural Resource Co., an estimated $2.55M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.

  • Baldwin Investment Management's largest Q2 2024 buy was Synopsys: 2,291 shares worth $1.36M.
  • Baldwin Investment Management added most to ExxonMobil in Q2 2024, an estimated $2.58M increase.
  • Baldwin Investment Management's biggest Q2 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $1.85M.
  • Baldwin Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $2.55M.
  • Baldwin Investment Management's ten largest holdings make up 61% of its $730M portfolio in Q2 2024.
  • Baldwin Investment Management opened 5 new positions and closed 9 in Q2 2024.
  • Baldwin Investment Management's portfolio value fell 0.97% quarter-over-quarter to $730M.

Based on Baldwin Investment Management's 13F filing for Q2 2024, filed 30 Jul 2024.